Literature DB >> 15111297

Inflammation and remyelination in the central nervous system: a tale of two systems.

Francesca Ruffini1, Timothy E Kennedy, Jack P Antel.   

Abstract

Mesh:

Year:  2004        PMID: 15111297      PMCID: PMC1615648          DOI: 10.1016/S0002-9440(10)63709-1

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


× No keyword cloud information.
  26 in total

1.  Widespread expression of netrin-1 by neurons and oligodendrocytes in the adult mammalian spinal cord.

Authors:  C Manitt; M A Colicos; K M Thompson; E Rousselle; A C Peterson; T E Kennedy
Journal:  J Neurosci       Date:  2001-06-01       Impact factor: 6.167

2.  The chemokine receptor CXCR2 controls positioning of oligodendrocyte precursors in developing spinal cord by arresting their migration.

Authors:  Hui-Hsin Tsai; Emma Frost; Vivien To; Shenandoah Robinson; Charles Ffrench-Constant; Robert Geertman; Richard M Ransohoff; Robert H Miller
Journal:  Cell       Date:  2002-08-09       Impact factor: 41.582

3.  Non-MHC-restricted cell-mediated lysis of human oligodendrocytes in vitro: relation with CD56 expression.

Authors:  J P Antel; E McCrea; U Ladiwala; Y F Qin; B Becher
Journal:  J Immunol       Date:  1998-02-15       Impact factor: 5.422

4.  Oligodendrocyte precursor cells in the demyelinated multiple sclerosis spinal cord.

Authors:  Guus Wolswijk
Journal:  Brain       Date:  2002-02       Impact factor: 13.501

5.  Spontaneous remyelination following extensive demyelination is associated with improved neurological function in a viral model of multiple sclerosis.

Authors:  P D Murray; D B McGavern; S Sathornsumetee; M Rodriguez
Journal:  Brain       Date:  2001-07       Impact factor: 13.501

6.  Premyelinating oligodendrocytes in chronic lesions of multiple sclerosis.

Authors:  Ansi Chang; Wallace W Tourtellotte; Richard Rudick; Bruce D Trapp
Journal:  N Engl J Med       Date:  2002-01-17       Impact factor: 91.245

7.  Patients with active relapsing-remitting multiple sclerosis synthesize antibodies recognizing oligodendrocyte progenitor cell surface protein: implications for remyelination.

Authors:  A Niehaus; J Shi; M Grzenkowski; M Diers-Fenger; J Archelos; H P Hartung; K Toyka; W Brück; J Trotter
Journal:  Ann Neurol       Date:  2000-09       Impact factor: 10.422

8.  NG2-positive oligodendrocyte progenitor cells in adult human brain and multiple sclerosis lesions.

Authors:  A Chang; A Nishiyama; J Peterson; J Prineas; B D Trapp
Journal:  J Neurosci       Date:  2000-09-01       Impact factor: 6.167

9.  Experimental autoimmune encephalomyelitis mobilizes neural progenitors from the subventricular zone to undergo oligodendrogenesis in adult mice.

Authors:  Nathalie Picard-Riera; Laurence Decker; Cécile Delarasse; Karine Goude; Brahim Nait-Oumesmar; Roland Liblau; Danielle Pham-Dinh; Anne Baron-Van Evercooren
Journal:  Proc Natl Acad Sci U S A       Date:  2002-09-16       Impact factor: 11.205

10.  Multiple sclerosis: re-expression of a developmental pathway that restricts oligodendrocyte maturation.

Authors:  Gareth R John; Sai Latha Shankar; Bridget Shafit-Zagardo; Aldo Massimi; Sunhee C Lee; Cedric S Raine; Celia F Brosnan
Journal:  Nat Med       Date:  2002-09-23       Impact factor: 53.440

View more
  4 in total

Review 1.  What do we know about the mechanism of action of disease-modifying treatments in MS?

Authors:  Hans-Peter Hartung; Amit Bar-Or; Yannis Zoukos
Journal:  J Neurol       Date:  2004-09       Impact factor: 4.849

2.  Simvastatin induces cell death in a mouse cerebellar slice culture (CSC) model of developmental myelination.

Authors:  Zhongmin Xiang; Steven A Reeves
Journal:  Exp Neurol       Date:  2008-09-27       Impact factor: 5.330

Review 3.  Remyelination Trials: Are We Expecting the Unexpected?

Authors:  Alexandr Klistorner; Michael Barnett
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2021-08-10

4.  15d-PGJ2 induces apoptosis of mouse oligodendrocyte precursor cells.

Authors:  Zhongmin Xiang; Tong Lin; Steven A Reeves
Journal:  J Neuroinflammation       Date:  2007-07-16       Impact factor: 8.322

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.